Alendronate Sodium Trihydrate
CAS:121268-17-5
Storage:Store at -20℃
Alendronate sodium hydroxyethyldronate sodium is a bone resorption inhibitor; Hexahydrofarnesyl diphosphate synthase inhibitors (farnesyldiphosphatesynthase) (IC50 = 460 nm); CD45 protein tyrosine phosphatase (proteintyrosinephosphatase) inhibitors. It is used in the treatment of postmenopausal osteoporosis and senile osteoporosis, osteoporosis, ectopic ossification, such as Paget's disease, deformable osteitis, kidney stones, malignant hypercalcemia and so on.
Note:Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
Remark:
These protocols are for reference only. Solarbio does not independently validate these
methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.